Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lefteris Floros

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vaccine|January 21, 2026
Serotype-specific incidence and comparative vaccine coverage of invasive pneumococcal disease among adults ≥65 years of age in European countries from 2011 to 2023Lefteris Floros, Kelly D Johnson, Eleana Tsoumani
BMJ (Clinical Research Ed.)|October 13, 2016
Authors' reply to TavabieChris Day, Jessica Glen, Lefteris Floros, et al.
BMJ (Clinical Research Ed.)|September 9, 2016
Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidanceJessica Glen, Lefteris Floros, Chris Day, et al.
BMC Infectious Diseases|February 13, 2019
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in SwedenLefteris Floros, Daniel Kuessner, Jan Posthumus, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|April 27, 2023
Cost Consequence Analysis of the Management of Hyperkalemia by Patiromer and Optimization of Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Chronic Kidney Disease Patients in Saudi ArabiaFaissal A M Shaheen, Aurelie Meunier, Abdulaziz Altowaijri, et al.
Journal of Medical Economics|July 3, 2019
The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United KingdomLefteris Floros, Antonio Pagliuca, Amer Al Taie, et al.
Human Vaccines & Immunotherapeutics|June 27, 2025
Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South KoreaYoung June Choe, Yunjin Jeon, Jihyun Park, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 22, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018Alice Morgan, Sally Hartmanis, Emmanuel Tsochatzis, et al.
International Journal of Surgery (London, England)|July 14, 2022
Ward based goal directed fluid therapy (GDFT) in acute pancreatitis (GAP) trial: A feasibility randomised controlled trialFarid Froghi, Fiammetta Soggiu, Federico Ricciardi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vaccine|January 21, 2026
Serotype-specific incidence and comparative vaccine coverage of invasive pneumococcal disease among adults ≥65 years of age in European countries from 2011 to 2023Lefteris Floros, Kelly D Johnson, Eleana Tsoumani
BMJ (Clinical Research Ed.)|October 13, 2016
Authors' reply to TavabieChris Day, Jessica Glen, Lefteris Floros, et al.
BMJ (Clinical Research Ed.)|September 9, 2016
Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidanceJessica Glen, Lefteris Floros, Chris Day, et al.
BMC Infectious Diseases|February 13, 2019
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in SwedenLefteris Floros, Daniel Kuessner, Jan Posthumus, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|April 27, 2023
Cost Consequence Analysis of the Management of Hyperkalemia by Patiromer and Optimization of Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Chronic Kidney Disease Patients in Saudi ArabiaFaissal A M Shaheen, Aurelie Meunier, Abdulaziz Altowaijri, et al.
Journal of Medical Economics|July 3, 2019
The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United KingdomLefteris Floros, Antonio Pagliuca, Amer Al Taie, et al.
Human Vaccines & Immunotherapeutics|June 27, 2025
Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South KoreaYoung June Choe, Yunjin Jeon, Jihyun Park, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 22, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018Alice Morgan, Sally Hartmanis, Emmanuel Tsochatzis, et al.
International Journal of Surgery (London, England)|July 14, 2022
Ward based goal directed fluid therapy (GDFT) in acute pancreatitis (GAP) trial: A feasibility randomised controlled trialFarid Froghi, Fiammetta Soggiu, Federico Ricciardi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
Pageof 1